Task: Answer the multiple-choice question.
Question: Which drug exhibits a -4.853\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCOc1ccc2nc(NCCNC(=O)Nc3cccc(C)c3)c(C#N)cc2c1
b.) COc1ccc(/C=C2\Sc3ccc(C(=O)NCCCN4CCCC4)cc3N(C)C2=O)cc1OC
Answer: b. COc1ccc(/C=C2\Sc3ccc(C(=O)NCCCN4CCCC4)cc3N(C)C2=O)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
(2Z)-2-[(3,4-dimethoxyphenyl)methylidene]-4-methyl-3-oxo-N-(3-pyrrolidin-1-ylpropyl)-1,4-benzothiazine-6-carboxamide